Igraine has invested in Fixit Medical Ltd (“Fixit”), the next generation drainage catheter fixation device.
Fixit, a research and experimental development company focused on social sciences and humanities, is the sole owner, designer and developer of Cingo® (“Cingo”), the next drainage catheter fixation device. Cingo features best in class catheter fixation through a pull-force dissipating design and an estimated two-week wear time. Cingo also boasts a revolutionary design that protects catheters from twisting and kinking, providing easy access to the catheter exit site for improved visibility and cleaning, and includes a breakthrough integral shower-safe feature.
Fixit CEO and Inventor of Cingo, Dr. Robert Ward, MB BS FRCS FRCR, is a specialist in vascular and interventional radiology and has developed the most advanced and patient-centric drainage catheter fixation device available today
Igraine will holds 434 ordinary shares in Fixit representing 20 per cent of Fixit’s share capital. Included in the subscription, Igraine secured rights of pre-emption on any new issues of shares by Fixit, although no further capital raises are anticipated.